This federal contract IDV is an interim agreement awarded under Federal Supply Schedule (FSS) 65 IB, which covers drugs, pharmaceuticals, and hematology-related products. The contract was awarded by the Veterans Integrated Service Network 12, a civilian agency of the U.S. federal government, to Immunogen Inc., a for-profit organization, on December 16, 2022. The contract has a ceiling value of $25,000.00 and an ultimate completion date of June 14, 2023.
The purpose of this contract is to provide interim agreement for the procurement of drug, pharmaceutical, and hematology-related products under the FSS 65 IB schedule. The contract does not have any set-asides and is a multiple award type. The place of performance and specific products or services to be delivered are not provided in the information given. The contract aims to fulfill the agency's need for these types of medical supplies and equipment, in support of its healthcare mission.
Generated 2/11/25, 10:06 AM